Industry Insights

  1. AI Is Not The CMC Revolution You're Looking For, And That's OK 11/18/2025

    Advanced therapy development today is less about big funding, more about frugality. Artificial intelligence unlocks a competitive advantage.

  2. How To Improve Sponsor–CMO Collaboration Around Digital Deviations 11/17/2025

    Digital strategies and standardized data models cut manual work, boost accuracy and speed of information sharing, and build trust between sponsors and CMOs.

  3. Solving The Stem Cell Consistency Conundrum With iMSCs 11/17/2025

    The ability to produce unlimited batches of induced mesenchymal stem cells from a single iPSC cell bank is, perhaps, one of their most alluring features.

  4. Sensitive Critical Starting Materials Need A 'Just-In-Data' Approach 11/14/2025

    Here's a blueprint for transforming the fragmented, high-risk interface between vector and cell therapy platforms into a unified, predictable, and compliant system.

  5. Exploring The Benefits Of Electroporation In NK Cell Transfection 11/14/2025

    Electroporation creates temporary holes in cell membranes for genetic material to slip through. The technique offers some key advantages to viral transduction.

  6. On The Potency Assurance Journey, Travelers Need A Road Map 11/13/2025

    When regulatory expectations change by the phase, the route can be difficult and confusing to navigate for both new and experienced potency investigators.

  7. It's Not Just You, Everyone's Talking About OPV 11/12/2025

    Ongoing process verification has evolved beyond a compliance exercise to a strategic priority thanks, in part, to technology advancements.

  8. When One Gene Isn't Enough: The Case For Gene-Agnostic Vision Rescue 11/7/2025

    The genetic diversity of retinitis pigmentosa challenges the one-gene-one-therapy model and positions RP as a proving ground for gene-agnostic treatments designed to preserve or restore visual function across genotypes.

  9. Notes From A VC: What It Takes To Be Impactful In Longevity Science 11/6/2025

    Impact in longevity science (particularly for cell and gene therapies) is not about chasing the next unicorn; it is about carrying transformative ideas across the threshold of scientific validation, regulatory trust, and societal acceptance.

  10. A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches 11/6/2025

    The transition from 2D to 3D cell culture requires a combination of advanced analytical techniques, but aligning new methods with established principles can be challenging.